Evidence map›Paper›PMID 39873526›Full record

ArticleMicrobiology spectrum2025

Optimal processing of tongue swab samples for

Gayatri Shankar Chilambi, Robert Reiss, Naranjargal Daivaa, Padmapriya Banada, Margaretha De Vos, Adam Penn-Nicholson, David Alland

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Gayatri Shankar ChilambiDepartment of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.ORCID 0000-0003-2387-6198
Robert ReissDepartment of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Naranjargal DaivaaDepartment of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Padmapriya BanadaDepartment of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.ORCID 0000-0002-5217-6142
Margaretha De VosFIND, Geneva, Switzerland.ORCID 0000-0003-3059-2986
Adam Penn-NicholsonFIND, Geneva, Switzerland.ORCID 0000-0002-1883-0059
David AllandDepartment of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.ORCID 0000-0001-5196-1571

Funding

FEND for TB supplement to accelerate BLINK X developmentU01AI152084 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI ALLAND, DAVID, DORMAN, SUSAN E · 2020 to 2024
$20.0M
HHS | National Institutes of Health (NIH) U01AI152084NIAID NIH HHS U01 AI152084
6 · The paper itself

Abstract

Tongue swabs represent a potential alternative to sputum as a sample type for detecting pulmonary tuberculosis (TB) with molecular diagnostic tests. The methods used to process tongue swabs for testing in the World Health Organization-recommended Xpert MTB/RIF Ultra (Xpert Ultra) assay vary greatly. Here, we aimed to identify the optimal tongue swab processing for Xpert Ultra testing. We compared four methods for treating dry tongue swabs with the Xpert Sample Reagent (SR) mixed with various concentrations of Tris-EDTA-Tween to treatment with SR alone or to a commonly used heat inactivation protocol. In each condition, swabs obtained from volunteers without TB were placed into test buffer spiked with known amounts of

Indexed as

Molecular Diagnostic TechniquesMycobacterium tuberculosisSpecimen HandlingTongueTuberculosisTuberculosis, PulmonaryHumansLimit of DetectionSensitivity and SpecificitySputummolecular diagnosticstongue swabtuberculosisXpert Ultra

Identifiers

PMID39873526
PMCPMC11878016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.